Verrica Pharmaceuticals Inc. Increase (Decrease) in Due to Related Parties, Current
Verrica Pharmaceuticals Inc. (VRCA) reported Increase (Decrease) in Due to Related Parties, Current of -$32.00 thousand for the 6-month period ending 2019-06-30, per its 10-Q filed 2019-08-07.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInDueToRelatedPartiesCurrent · last filed 2019-08-07
- Verrica Pharmaceuticals Inc. increase (decrease) in due to related parties, current for the quarter ending 2019-06-30 was $6.00K, a 79.31% decline year-over-year.
- Verrica Pharmaceuticals Inc. increase (decrease) in due to related parties, current for the quarter ending 2019-03-31 was -$38.00K.
- Verrica Pharmaceuticals Inc. increase (decrease) in due to related parties, current for the quarter ending 2018-12-31 was $0.00.
- Verrica Pharmaceuticals Inc. increase (decrease) in due to related parties, current for the quarter ending 2018-09-30 was $2.00K, a 98.06% decline year-over-year.
- Verrica Pharmaceuticals Inc. increase (decrease) in due to related parties, current for fiscal 2018 was $24.00K.
- Verrica Pharmaceuticals Inc. increase (decrease) in due to related parties, current for fiscal 2017 was -$22.00K.
| Period end | Increase (Decrease) in Due to Related Parties, Current 3 month | Increase (Decrease) in Due to Related Parties, Current 6 month | Increase (Decrease) in Due to Related Parties, Current 9 month | Increase (Decrease) in Due to Related Parties, Current 12 month |
|---|---|---|---|---|
| 2019-06-30 | $6.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-07 | -$32.00K 10-Q · filed 2019-08-07 | -$32.00K derived: sum of 3 quarters · filed 2019-08-07 | -$30.00K derived: sum of 4 quarters · filed 2019-08-07 |
| 2019-03-31 | -$38.00K 10-Q · filed 2019-05-07 | -$38.00K derived: sum of 2 quarters · filed 2019-05-07 | -$36.00K derived: sum of 3 quarters · filed 2019-05-07 | -$7.00K derived: sum of 4 quarters · filed 2019-08-07 |
| 2018-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-07 | $2.00K derived: sum of 2 quarters · filed 2019-03-07 | $31.00K derived: sum of 3 quarters · filed 2019-08-07 | $24.00K 10-K · filed 2019-03-07 |
| 2018-09-30 | $2.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-07 | $31.00K derived: sum of 2 quarters · filed 2019-08-07 | $24.00K 10-Q · filed 2018-11-07 | -$126.00K derived: sum of 4 quarters · filed 2019-08-07 |
| 2018-06-30 | $29.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-07 | $22.00K 10-Q · filed 2019-08-07 | -$128.00K derived: sum of 3 quarters · filed 2019-08-07 | -$25.00K derived: sum of 4 quarters · filed 2019-08-07 |
| 2018-03-31 | -$7.00K 10-Q · filed 2019-05-07 | -$157.00K derived: sum of 2 quarters · filed 2019-05-07 | -$54.00K derived: sum of 3 quarters · filed 2019-05-07 | |
| 2017-12-31 | -$150.00K derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-07 | -$47.00K derived: sum of 2 quarters · filed 2019-03-07 | -$22.00K 10-K · filed 2019-03-07 | |
| 2017-09-30 | $103.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-07 | $128.00K 10-Q · filed 2018-11-07 | ||
| 2017-06-30 | $25.00K 10-Q · filed 2018-08-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| OS Therapies Inc (OSTX) | United States | $0.076B | -2.17 |
| iBio, Inc. (IBIO) | United States | $0.077B | -2.94 |
| MAIA Biotechnology, Inc. (MAIA) | United States | $0.077B | -2.30 |
| Valion Bio, Inc. (VBIO) | United States | $0.077B | |
| Adicet Bio, Inc. (ACET) | United States | $0.078B | -0.81 |
| Lifevantage Corp (LFVN) | United States | $0.078B | 15.40 |
| Aldeyra Therapeutics, Inc. (ALDX) | United States | $0.074B | -5.57 |
| Cingulate Inc. (CING) | United States | $0.073B | -2.64 |
| Spero Therapeutics, Inc. (SPRO) | United States | $0.073B | 17.41 |
| Gain Therapeutics, Inc. (GANX) | United States | $0.080B | -4.40 |